This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.
Human medicines European public assessment report (EPAR): Quviviq, daridorexant,...
European Shortages Monitoring (ESMP) - Question and answer clinic for marketing ...
US president says Ross Ulbricht was victim of ‘weaponisation of government’
Nominee says he is entitled to 10% of proceeds if case against Merck’s Gardasil ...
Sector knocked by disappointing sales, an unexpected trial result and questions ...
The San Francisco-based start-up plans to get its first drug into trials this year
New deal is $1.4bn higher than previous one struck down by Supreme Court last year
US president threatens to double tax rates for foreign nationals and companies
People treated with amycretin lost up to 22% of their body weight after 36 weeks
FTSE’s most valuable company faces potential fine over suspected unpaid taxes in...
Drugmaker pins hopes on launch of new medicines but key point is to avoid re-tra...
Shares rebound after disappointing sales of blockbuster medications last year le...
How an agreement set up by the Tories and lauded by Labour fell victim to cost-c...
Efficacy of the drugs has driven their success, but the potential side-effects p...
Private equity firm expects $3.3bn acquisition of Tanabe will get boost from eas...
EMA has published an overview of its key recommendations of 2024 regarding the a...
FDA approved the first generic referencing Victoza (liraglutide injection) 18 mg...
Today, the FDA approved the first medication for the treatment of moderate to se...
The U.S. Food and Drug Administration is providing an at-a-glance summary of new...